PortfoliosLab logoPortfoliosLab logo
CLOV vs. OWLT
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

CLOV vs. OWLT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Clover Health Investments, Corp. (CLOV) and Owlet, Inc. (OWLT). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CLOV achieves a 58.72% return, which is significantly higher than OWLT's -67.57% return.


CLOV

1D
-4.85%
1M
37.64%
YTD
58.72%
6M
49.80%
1Y
17.67%
3Y*
61.60%
5Y*
-16.04%
10Y*

OWLT

1D
-4.37%
1M
8.47%
YTD
-67.57%
6M
-59.37%
1Y
-13.93%
3Y*
19.45%
5Y*
-48.10%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

CLOV vs. OWLT - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
CLOV
Clover Health Investments, Corp.
58.72%-25.40%230.85%2.43%-75.01%-77.82%66.37%
OWLT
Owlet, Inc.
-67.57%263.82%-15.72%-32.54%-79.06%-73.75%4.85%

Correlation

The correlation between CLOV and OWLT is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.16

Correlation (3Y)
Calculated over the trailing 3-year period

0.14

Correlation (5Y)
Calculated over the trailing 5-year period

0.20

Correlation (All Time)
Calculated using the full available price history since Nov 6, 2020

0.19

Fundamentals

Market Cap

CLOV:

$1.95B

OWLT:

$19.07B

EPS

CLOV:

-$0.11

OWLT:

-$0.04

PS Ratio

CLOV:

0.87

OWLT:

51.83

PB Ratio

CLOV:

5.74

OWLT:

1.29K

Total Revenue (TTM)

CLOV:

$2.21B

OWLT:

$107.06M

Gross Profit (TTM)

CLOV:

$939.14M

OWLT:

$54.38M

EBITDA (TTM)

CLOV:

-$55.21M

OWLT:

-$17.58M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CLOV vs. OWLT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CLOV
CLOV Risk / Return Rank: 4949
Overall Rank
CLOV Sharpe Ratio Rank: 5050
Sharpe Ratio Rank
CLOV Sortino Ratio Rank: 5050
Sortino Ratio Rank
CLOV Omega Ratio Rank: 5050
Omega Ratio Rank
CLOV Calmar Ratio Rank: 4848
Calmar Ratio Rank
CLOV Martin Ratio Rank: 4747
Martin Ratio Rank

OWLT
OWLT Risk / Return Rank: 3838
Overall Rank
OWLT Sharpe Ratio Rank: 3434
Sharpe Ratio Rank
OWLT Sortino Ratio Rank: 3939
Sortino Ratio Rank
OWLT Omega Ratio Rank: 3939
Omega Ratio Rank
OWLT Calmar Ratio Rank: 3939
Calmar Ratio Rank
OWLT Martin Ratio Rank: 3838
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CLOV vs. OWLT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Clover Health Investments, Corp. (CLOV) and Owlet, Inc. (OWLT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


CLOVOWLTDifference

Sharpe ratio

Return per unit of total volatility

0.26

-0.16

+0.42

Sortino ratio

Return per unit of downside risk

0.88

0.39

+0.49

Omega ratio

Gain probability vs. loss probability

1.11

1.05

+0.06

Calmar ratio

Return relative to maximum drawdown

0.34

-0.04

+0.38

Martin ratio

Return relative to average drawdown

0.62

-0.08

+0.70

CLOV vs. OWLT - Sharpe Ratio Comparison

The current CLOV Sharpe Ratio is 0.26, which is higher than the OWLT Sharpe Ratio of -0.16. The chart below compares the historical Sharpe Ratios of CLOV and OWLT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


CLOVOWLTDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.26

-0.16

+0.42

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.18

-0.53

+0.35

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.18

-0.52

+0.34

Drawdowns

CLOV vs. OWLT - Drawdown Comparison

The maximum CLOV drawdown since its inception was -97.19%, roughly equal to the maximum OWLT drawdown of -98.14%. Use the drawdown chart below to compare losses from any high point for CLOV and OWLT.


Loading charts...

Drawdown Indicators


CLOVOWLTDifference

Max Drawdown

Largest peak-to-trough decline

-97.19%

-98.14%

+0.95%

Max Drawdown (1Y)

Largest decline over 1 year

-55.50%

-72.58%

+17.08%

Max Drawdown (3Y)

Largest decline over 3 years

-64.73%

-72.58%

+7.85%

Max Drawdown (5Y)

Largest decline over 5 years

-97.19%

-98.06%

+0.87%

Current Drawdown

Current decline from peak

-83.16%

-96.52%

+13.36%

Average Drawdown

Average peak-to-trough decline

-76.62%

-77.91%

+1.29%

Ulcer Index

Depth and duration of drawdowns from previous peaks

30.54%

35.97%

-5.43%

Volatility

CLOV vs. OWLT - Volatility Comparison

The current volatility for Clover Health Investments, Corp. (CLOV) is 22.50%, while Owlet, Inc. (OWLT) has a volatility of 25.97%. This indicates that CLOV experiences smaller price fluctuations and is considered to be less risky than OWLT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CLOVOWLTDifference

Volatility (1M)

Calculated over the trailing 1-month period

22.50%

25.97%

-3.47%

Volatility (6M)

Calculated over the trailing 6-month period

39.35%

71.40%

-32.05%

Volatility (1Y)

Calculated over the trailing 1-year period

68.61%

87.24%

-18.63%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

88.12%

90.41%

-2.29%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

85.66%

85.82%

-0.16%

Dividends

CLOV vs. OWLT - Dividend Comparison

Neither CLOV nor OWLT has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

CLOV vs. OWLT - Financials Comparison

This section allows you to compare key financial metrics between Clover Health Investments, Corp. and Owlet, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00200.00M400.00M600.00M800.00M20222023202420252026
749.19M
22.50M
(CLOV) Total Revenue
(OWLT) Total Revenue
Values in USD except per share items

CLOV vs. OWLT - Profitability Comparison

The chart below illustrates the profitability comparison between Clover Health Investments, Corp. and Owlet, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

-20.0%0.0%20.0%40.0%60.0%80.0%100.0%20222023202420252026
92.4%
54.2%
Portfolio components
CLOV - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Clover Health Investments, Corp. reported a gross profit of 692.13M and revenue of 749.19M. Therefore, the gross margin over that period was 92.4%.

OWLT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Owlet, Inc. reported a gross profit of 12.20M and revenue of 22.50M. Therefore, the gross margin over that period was 54.2%.

CLOV - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Clover Health Investments, Corp. reported an operating income of 27.33M and revenue of 749.19M, resulting in an operating margin of 3.7%.

OWLT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Owlet, Inc. reported an operating income of -5.60M and revenue of 22.50M, resulting in an operating margin of -24.9%.

CLOV - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Clover Health Investments, Corp. reported a net income of 27.33M and revenue of 749.19M, resulting in a net margin of 3.7%.

OWLT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Owlet, Inc. reported a net income of -4.10M and revenue of 22.50M, resulting in a net margin of -18.2%.


Frequently Asked Questions


CLOV and OWLT have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

OWLT has higher volatility (25.97%) compared to CLOV (22.50%). In terms of maximum drawdown, CLOV dropped -97.19% vs OWLT's -98.14%.

CLOV currently has the higher Sharpe Ratio (0.26 vs -0.16), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CLOV and OWLT

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer